The emerging therapy of the medication represents a significant advance in the care of diabetes mellitus type 2. Different to existing therapies, tirzepatide impacts two pathways – the GLP-1 hormone and the GIP https://tirzepatide-peptide930044.ssnblog.com/40585013/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment